Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00469378
Recruitment Status : Completed
First Posted : May 4, 2007
Last Update Posted : March 23, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : May 2009
Actual Study Completion Date : February 2010
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 July 24, 2017
(Canceled - Date Unknown)
July 25, 2017
February 9, 2018
2 February 14, 2018
(Canceled - Date Unknown)
March 5, 2018
(Canceled on August 15, 2018)